Drugs / DK210
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05704985 | Apr 2023 → Jul 2025 overdue | colorectal cancer, female reproductive organ cancer, head and neck cancer, kidney cancer +3 | DEKA Biosciences | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DK210 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05704985 ↗ |